|
PIGQ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.166000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.087200E-01 |
| Normal-vs-Stage2 |
7.814400E-01 |
| Normal-vs-Stage3 |
8.197400E-01 |
| Normal-vs-Stage4 |
1.200970E-01 |
| Stage1-vs-Stage2 |
3.571200E-01 |
| Stage1-vs-Stage3 |
3.211600E-01 |
| Stage1-vs-Stage4 |
1.375400E-01 |
| Stage2-vs-Stage3 |
9.587600E-01 |
| Stage2-vs-Stage4 |
3.796200E-01 |
| Stage3-vs-Stage4 |
3.709000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.709400E-01 |
| Normal-vs-AfricanAmerican |
5.804600E-01 |
| Normal-vs-Asian |
2.916500E-02 |
| Caucasian-vs-AfricanAmerican |
7.947200E-01 |
| Caucasian-vs-Asian |
8.483700E-02 |
| AfricanAmerican-vs-Asian |
1.431450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.112400E-01 |
| Normal-vs-Female |
4.977000E-01 |
| Male-vs-Female |
2.986400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.063600E-01 |
| Normal-vs-Extreme_Weight |
2.443400E-01 |
| Normal-vs-Obese |
3.787800E-01 |
| Normal-vs-Extreme_Obese |
7.293400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.800600E-01 |
| Normal_Weight-vs-Obese |
4.437400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.386600E-01 |
| Extreme_Weight-vs-Obese |
9.443200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.688600E-01 |
| Obese-vs-Extreme_Obese |
9.191000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.815200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.268600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.332610E-01 |
| Normal-vs-Age(81-100Yrs) |
1.229380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.113400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.240800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.644400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.340200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.844000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.157000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.966800E-04 |
| Normal-VS-Type2 PRCC |
2.303600E-02 |
| Normal-VS-KIRP CIMP |
1.711650E-02 |
| Normal-VS-Unclassified PRCC |
9.017000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.66169999561117E-09 |
| Type1 PRCC-VS-KIRP CIMP |
4.720700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.595900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.060000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.685700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.482500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.874200E-01 |
| Normal-vs-N1 |
2.386000E-01 |
| Normal-vs-N2 |
9.573000E-01 |
| N0-vs-N1 |
4.168200E-01 |
| N0-vs-N2 |
9.193800E-01 |
| N1-vs-N2 |
6.374200E-01 |
|
|
